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Tobacco control: new resources, existing treaties, and
emerging challenges
International investment in tobacco control is more important than ever
Linda Bauld Bruce and John Usher professor of public health
Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh EH8 9AG, UK
Tobacco use remains the leading preventable cause of death in
the world.1 Three research papers in The BMJ examine smoking
and efforts to deal with it, and these studies pose important
questions about progress made and where to go next.
Hoffman and colleagues describe a new open access dataset,
the International Cigarette Consumption Database (ICCD).2 In
their paper (doi:10.1136/bmj.l2231), they chronicle an ambitious
programme of work to identify, review, and report estimates of
cigarette consumption from sales and other data in 214 countries
(former and present). The ICCD includes 71 countries where
reliable data were available from 1970 to 2015. It identifies a
decline in cigarette consumption per capita in most countries
in the past three decades, but also substantial increases in China
and Indonesia, and a doubling of consumption in Russia in the
years immediately after the collapse of the former Soviet Union.
This valuable dataset is now freely available and provides a tool
for future research to assess trends and monitor the impact of
interventions.
Although the ICCD covers 85% of the world’s population, the
researchers struggled to find reliable data for many countries,
particularly in Africa. These data complement but cannot replace
prevalence surveys that provide valuable information on
smoking across different groups in the population. The ICCD
also focuses on cigarettes and excludes other tobacco products,
including smokeless tobacco, consumed by 300 million people
and linked to cancer, heart disease, and adverse pregnancy
outcomes when used in its more harmful forms.3
Framework convention on tobacco control
The ICCD was used in Hoffman and colleagues’ second paper
(doi:10.1136/bmj.l2287) to evaluate the impact of the
Framework Convention on Tobacco Control (FCTC).4 The
FCTC is an international treaty adopted in 2003 that required
its 181 signatories to implement evidence based measures for
tobacco control. The researchers used interrupted time series
analysis and forecast event modelling to assess cigarette
consumption levels before and after 2003 for the countries in
the ICCD. They concluded that the FCTC had not accelerated
existing declines in consumption overall, but they did find highly
variable patterns. High income countries saw large reductions
in smoking, but low and middle income countries and Asian
countries increased cigarette consumption per capita.
At face value, these findings suggest that the FCTC has not yet
delivered on its main objective, to reduce smoking and
associated harms. But that interpretation is too simplistic, given
divergence across countries. As smoking began to fall in high
income countries (a trend that began before the treaty), tobacco
manufacturers turned their attention to new markets in low and
middle income countries where the industry saw the potential
for growth. These countries had limited capacity to combat
industry attempts to delay or derail FCTC policies.5
Previous research found that full implementation of tobacco
taxes, smoke-free laws, advertising bans, and cessation support,
through robust legislation and rigorous enforcement did result
in substantial declines in prevalence.6 The more measures were
fully implemented, the greater the rate of decline. But in many
countries, particularly low and middle income countries, FCTC
implementation has been slow. The key lesson from Hoffman
and colleagues’ second paper is that ongoing efforts to support
FCTC countries to deliver on their obligations are urgently
needed. This is not a failure of the treaty but a call for continued
investment in international tobacco control to increase capacity,
improve governance, and enhance cooperation across countries
to combat tobacco industry influence.
E-cigarettes
While countries have been attempting to implement the FCTC,
the market has evolved and new products have emerged, most
notably electronic cigarettes that do not contain tobacco but
deliver nicotine (when present) in an aerosol. Existing research
suggests that e-cigarettes are less harmful than smoking7 and
can help smokers quit,8 and can appeal to young people. In the
third paper (doi:10.1136/bmj.l2219), Hammond and colleagues
provide new evidence from repeat cross sectional surveys of
16-19 year olds in the United States, Canada, and England.9
They report that recent and regular vaping increased in both
North American countries between 2017 and 2018. At least part
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of this increase could have been driven by new vaping products
that contain nicotine salts and are discreet to use. Worryingly,
smoking prevalence in 16-19 year olds also increased in Canada
during the same period, but not the US. By contrast, no
significant increase in vaping or smoking was found in England.
While the characteristics of young people are unlikely to vary
substantially between North America and England, the policy
environment is substantially different.10 Initially through
European legislation with subsequent domestic additions,
England has introduced a ban on most forms of e-cigarette
marketing and limits on nicotine concentration in vapour
products. In addition, mass media campaigns promote vaping
for smoking cessation in adults and contain very different
messages from industry marketing tactics. Research is ongoing
in all three countries, but more is needed to understand the
relation between the use of these products and other relevant
developments such as the legalisation of cannabis in Canada
and parts of the US.
Taken together, these new studies emphasise the value of
comparative research for tobacco control across different
countries. They also warn against complacency in our attempts
to address smoking, now and in the future.
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